Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Serum and CSF biomarkers in acute pediatric neurological disorders.

Shiihara T, Miyake T, Izumi S, Sugihara S, Watanabe M, Takanashi J, Kubota M, Kato M.

Brain Dev. 2014 Jun;36(6):489-95. doi: 10.1016/j.braindev.2013.06.011. Epub 2013 Jul 11.

PMID:
23850003
2.

Serum and cerebrospinal fluid S100B, neuron-specific enolase, and total tau protein in acute encephalopathy with biphasic seizures and late reduced diffusion: a diagnostic validity.

Shiihara T, Miyake T, Izumi S, Watanabe M, Kamayachi K, Kodama K, Nabetani M, Ikemiyagi M, Yamaguchi Y, Sawaura N.

Pediatr Int. 2012 Feb;54(1):52-5. doi: 10.1111/j.1442-200X.2011.03454.x. Epub 2011 Oct 30.

PMID:
21883688
3.

Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain-Barré syndrome.

Wang XK, Zhang HL, Meng FH, Chang M, Wang YZ, Jin T, Mix E, Zhu J.

Neurol Sci. 2013 May;34(5):655-61. doi: 10.1007/s10072-012-1092-z. Epub 2012 Apr 22.

PMID:
22526766
4.

The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage.

Moritz S, Warnat J, Bele S, Graf BM, Woertgen C.

J Neurosurg Anesthesiol. 2010 Jan;22(1):21-31. doi: 10.1097/ANA.0b013e3181bdf50d.

PMID:
20027011
5.

Neuron-specific enolase and S100B protein levels in recreational scuba divers with neurological decompression sickness.

Gempp E, Louge P, De Maistre S, Emile L, Blatteau JE.

Diving Hyperb Med. 2014 Mar;44(1):26-9.

PMID:
24687482
6.

α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.

Mollenhauer B, Locascio JJ, Schulz-Schaeffer W, Sixel-Döring F, Trenkwalder C, Schlossmacher MG.

Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X. Erratum in: Lancet Neurol. 2011 Apr;10(4):297.

PMID:
21317042
7.

Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy.

Kaciński M, Budziszewska B, Lasoń W, Zając A, Skowronek-Bała B, Leśkiewicz M, Kubik A, Basta-Kaim A.

Pharmacol Rep. 2012;64(6):1427-33.

8.

Structural biomarkers in the cerebrospinal fluid within 24 h after a traumatic spinal cord injury: a descriptive analysis of 16 subjects.

Pouw MH, Kwon BK, Verbeek MM, Vos PE, van Kampen A, Fisher CG, Street J, Paquette SJ, Dvorak MF, Boyd MC, Hosman AJ, van de Meent H.

Spinal Cord. 2014 Jun;52(6):428-33. doi: 10.1038/sc.2014.26. Epub 2014 Apr 8.

PMID:
24710150
9.

Brain-derived protein concentrations in the cerebrospinal fluid: contribution of trauma resulting from ventricular drain insertion.

Brandner S, Thaler C, Buchfelder M, Kleindienst A.

J Neurotrauma. 2013 Jul 1;30(13):1205-10. doi: 10.1089/neu.2012.2621. Epub 2013 Jun 25.

PMID:
23390981
10.

Serum biochemical markers of central nerve system damage in children with acute elemental mercury intoxicatıon.

Yılmaz FM, Yılmaz H, Tutkun E, Uysal S, Carman KB, Dılber C, Ercan M.

Clin Toxicol (Phila). 2014 Jan;52(1):32-8. doi: 10.3109/15563650.2013.860986.

PMID:
24400932
11.

Modeling serum biomarkers S100 beta and neuron-specific enolase as predictors of outcome after out-of-hospital cardiac arrest: an aid to clinical decision making.

Einav S, Kaufman N, Algur N, Kark JD.

J Am Coll Cardiol. 2012 Jul 24;60(4):304-11. doi: 10.1016/j.jacc.2012.04.020.

12.

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children.

Berger RP, Adelson PD, Pierce MC, Dulani T, Cassidy LD, Kochanek PM.

J Neurosurg. 2005 Jul;103(1 Suppl):61-8.

PMID:
16122007
13.

Prognostic value of biochemical markers of brain damage and oxidative stress in post-surgical aneurysmal subarachnoid hemorrhage patients.

Kaneda K, Fujita M, Yamashita S, Kaneko T, Kawamura Y, Izumi T, Tsuruta R, Kasaoka S, Maekawa T.

Brain Res Bull. 2010 Jan 15;81(1):173-7. doi: 10.1016/j.brainresbull.2009.10.020.

PMID:
19887101
14.

S100B and NSE as useful postmortem biochemical markers of traumatic brain injury in autopsy cases.

Ondruschka B, Pohlers D, Sommer G, Schober K, Teupser D, Franke H, Dressler J.

J Neurotrauma. 2013 Nov 15;30(22):1862-71. doi: 10.1089/neu.2013.2895. Epub 2013 Sep 19.

PMID:
23796187
15.
16.

Neuron-specific enolase, S100B, and glial fibrillary acidic protein levels as outcome predictors in patients with severe traumatic brain injury.

Böhmer AE, Oses JP, Schmidt AP, Perón CS, Krebs CL, Oppitz PP, D'Avila TT, Souza DO, Portela LV, Stefani MA.

Neurosurgery. 2011 Jun;68(6):1624-30; discussion 1630-1. doi: 10.1227/NEU.0b013e318214a81f.

PMID:
21368691
17.

Diagnostic value of S100B protein in the differential diagnosis of acute vertigo in the emergency department.

Kartal AG, Yılmaz S, Yaka E, Pekdemir M, Sarısoy HT, Çekmen MB, Yüksel M.

Acad Emerg Med. 2014 Jul;21(7):736-41. doi: 10.1111/acem.12420.

18.

Elevated levels of cerebrospinal fluid neuron-specific enolase (NSE), but not S100B in major depressive disorder.

Schmidt FM, Mergl R, Stach B, Jahn I, Schönknecht P.

World J Biol Psychiatry. 2015 Feb;16(2):106-13. doi: 10.3109/15622975.2014.952776. Epub 2014 Sep 29.

PMID:
25264292
19.

Folate and methylation status in relation to phosphorylated tau protein(181P) and beta-amyloid(1-42) in cerebrospinal fluid.

Obeid R, Kasoha M, Knapp JP, Kostopoulos P, Becker G, Fassbender K, Herrmann W.

Clin Chem. 2007 Jun;53(6):1129-36. Epub 2007 Mar 23.

20.

Brain biomarkers and management of uncertainty in predicting outcome of cardiopulmonary resuscitation: a nomogram paints a thousand words.

Einav S, Kaufman N, Algur N, Strauss-Liviatan N, Kark JD.

Resuscitation. 2013 Aug;84(8):1083-8. doi: 10.1016/j.resuscitation.2013.01.031. Epub 2013 Feb 4.

PMID:
23391666

Supplemental Content

Support Center